Matches in SemOpenAlex for { <https://semopenalex.org/work/W4240594564> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4240594564 abstract "P38δ Mitogen activated protein kinase is a serine/threonine protein kinase that participates in signaling cascades, mediating cellular responses to cytokinines, UV radiation, hyperosmotic stress, inducing keratinocyte differentiation and regulating apoptosis. Over expression of p38δ leads to tumor development by impairing the ERK1/2 –AP1 pathway that is critically linked to the control of cell proliferation and tumorigenesis on skin which was experimentally proven in knockout mice. Therefore, herein, a computational approach was undertaken to design novel inhibitors against p38delta for effective cancer therapy. The tertiary structure of p38δ was retrieved from a protein databank and active sites were predicted from CASTP and site finder and were optimized by applying OPLS force field in Maestro v9.0. Four p38δ specific inhibitors 4-(4-(2-(cyclopentylamino)pyrimidin-4-yl)-1H-pyrazol-3-yl)cyclohexanol,(R)-2-(sec-butylamino)-N-(2-methyl-5-(methylcarbamoyl)phenyl)thiazole-5-carboxamide, BIRB796 and ANP were selected from the literature for high throughput screening against one million compounds from the Ligand.Info metadatabase to generate an in-house library of 1515 structural analogs. The ligand library was prepared using LigPrep and compounds with ADME violations were discarded from the dataset. The candidates from the optimized ligand dataset were docked into the active site of p38δ through sequential application of Glide HTVS, SP and XP methods that penalizes more stringently for minor steric classes subsequently. Through comparative analysis of binding orientations and the XP G-score of the protein-ligand docking complexes with published inhibitor data, 4 lead molecules with the lowest docking scores(-12.12,-10.06,-9.47 and-9.36) are proposed to be considered as potential inhibitors of p38δ. The lead molecules would be highly encouraging for future cancer therapy if tested in animal models." @default.
- W4240594564 created "2022-05-12" @default.
- W4240594564 creator A5039684215 @default.
- W4240594564 creator A5058385663 @default.
- W4240594564 creator A5059114659 @default.
- W4240594564 creator A5071587604 @default.
- W4240594564 date "2010-12-30" @default.
- W4240594564 modified "2023-10-16" @default.
- W4240594564 title "Identification of potent inhibitors for p38δ MAPkinase of human through in silico analysis" @default.
- W4240594564 doi "https://doi.org/10.1038/npre.2010.5459" @default.
- W4240594564 hasPublicationYear "2010" @default.
- W4240594564 type Work @default.
- W4240594564 citedByCount "0" @default.
- W4240594564 crossrefType "journal-article" @default.
- W4240594564 hasAuthorship W4240594564A5039684215 @default.
- W4240594564 hasAuthorship W4240594564A5058385663 @default.
- W4240594564 hasAuthorship W4240594564A5059114659 @default.
- W4240594564 hasAuthorship W4240594564A5071587604 @default.
- W4240594564 hasBestOaLocation W42405945641 @default.
- W4240594564 hasConcept C103697762 @default.
- W4240594564 hasConcept C104317684 @default.
- W4240594564 hasConcept C116569031 @default.
- W4240594564 hasConcept C159110408 @default.
- W4240594564 hasConcept C170493617 @default.
- W4240594564 hasConcept C184235292 @default.
- W4240594564 hasConcept C185592680 @default.
- W4240594564 hasConcept C202751555 @default.
- W4240594564 hasConcept C2775905019 @default.
- W4240594564 hasConcept C41685203 @default.
- W4240594564 hasConcept C51551487 @default.
- W4240594564 hasConcept C55493867 @default.
- W4240594564 hasConcept C56173144 @default.
- W4240594564 hasConcept C69366308 @default.
- W4240594564 hasConcept C70721500 @default.
- W4240594564 hasConcept C71924100 @default.
- W4240594564 hasConcept C86803240 @default.
- W4240594564 hasConcept C97029542 @default.
- W4240594564 hasConceptScore W4240594564C103697762 @default.
- W4240594564 hasConceptScore W4240594564C104317684 @default.
- W4240594564 hasConceptScore W4240594564C116569031 @default.
- W4240594564 hasConceptScore W4240594564C159110408 @default.
- W4240594564 hasConceptScore W4240594564C170493617 @default.
- W4240594564 hasConceptScore W4240594564C184235292 @default.
- W4240594564 hasConceptScore W4240594564C185592680 @default.
- W4240594564 hasConceptScore W4240594564C202751555 @default.
- W4240594564 hasConceptScore W4240594564C2775905019 @default.
- W4240594564 hasConceptScore W4240594564C41685203 @default.
- W4240594564 hasConceptScore W4240594564C51551487 @default.
- W4240594564 hasConceptScore W4240594564C55493867 @default.
- W4240594564 hasConceptScore W4240594564C56173144 @default.
- W4240594564 hasConceptScore W4240594564C69366308 @default.
- W4240594564 hasConceptScore W4240594564C70721500 @default.
- W4240594564 hasConceptScore W4240594564C71924100 @default.
- W4240594564 hasConceptScore W4240594564C86803240 @default.
- W4240594564 hasConceptScore W4240594564C97029542 @default.
- W4240594564 hasLocation W42405945641 @default.
- W4240594564 hasOpenAccess W4240594564 @default.
- W4240594564 hasPrimaryLocation W42405945641 @default.
- W4240594564 hasRelatedWork W2169748008 @default.
- W4240594564 hasRelatedWork W2905923323 @default.
- W4240594564 hasRelatedWork W2969132017 @default.
- W4240594564 hasRelatedWork W3094628600 @default.
- W4240594564 hasRelatedWork W3122772507 @default.
- W4240594564 hasRelatedWork W3135706395 @default.
- W4240594564 hasRelatedWork W4240594564 @default.
- W4240594564 hasRelatedWork W4251172047 @default.
- W4240594564 hasRelatedWork W4306911903 @default.
- W4240594564 hasRelatedWork W4378801438 @default.
- W4240594564 isParatext "false" @default.
- W4240594564 isRetracted "false" @default.
- W4240594564 workType "article" @default.